Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with ...

A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in triple-negative breast cancer patients.

"These are complex algorithms, but in general, the software takes in a list of mutations and interprets them in the context of their potential to be good neoantigen candidates. The tools rank the ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive ...

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...